Showing results (2761-2770 of 2,776) with videos related to
Sort By:
Pageof 278
Bioanalysis|May 14, 2026
Comparison of 2D-LC and LC-MS/MS self- calibration internal standard method for the determination of quetiapine in serumMengli Ding, Xiaodan Li, Bi Zhang, et al.Bioanalysis|May 19, 2026
Optimizing acid type and pH for dissociation of biotin-labeled drug from streptavidin-coated bead in BEAD ADA assaysLili Guo, Yong Jiang, Christopher EhlingerBioanalysis|May 24, 2026
European bioanalysis forum recommendations for strengthening bioanalytical method transfer and validation through collaborative interactionsLene Andersen, Fabian Gaertner, Sibel Ahmedova, et al.Bioanalysis|April 27, 2026
Overcoming inconsistent DNA extraction recovery across tissue types in qPCR assays supporting biodistribution studiesTing Jiang, Zhaomeng Feng, Long YuanBioanalysis|May 15, 2026
From tiers to truth - a biomarker-based framework for clinically relevant immunogenicity assessmentLauren F StevensonBioanalysis|October 22, 2013
Conference report: reviving pharmaceutical R&D with translational science, regulatory efficiency and innovative modelsTianyi Tee Zhang, Naidong Weng, Mike LeeBioanalysis|December 16, 2020
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approvalYunfeng Lv, Jingyun He, Rongzhi Liu, et al.Bioanalysis|August 7, 2026
Advanced assay design for characterizing anti-drug antibody responses in clinical serum samplesGregor P Lotz, Denise Sickert, Roland F Staack, et al.Bioanalysis|August 26, 2026
From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilarsAnita Krishnan, Somesh Bp, Gaurav Mehta, et al.Bioanalysis|September 13, 2026
From ADA positivity to clinical decision: a context-of-use framework for reflex testing, sampling frequency and stopping rules in immunogenicity assessmentAhmad Z Al Meslamani, Anan S Jarab, Husam El Sharu, et al.Pageof 278